By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chiesi, USA (Formerly Known As Cornerstone Therapeutics) 

1255 Crescent Green Drive
Suite 250
Cary  North Carolina  27518  U.S.A.
Phone: 888-466-6505 Fax: n/a


Chiesi USA, Inc., headquartered in Cary, NC, is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, as well as rare diseases.

Previously known as Cornerstone Therapeutics Inc, Chiesi USA is now a wholly-owned subsidiary of Chiesi Farmaceutici, S.p.A., based in Parma, Italy. The family-owned and operated Chiesi Group has over 80 years’ experience researching, developing and commercializing innovative medicines. Chiesi was recently named one of the top 50 pharmaceutical companies worldwide, operating in 26 countries and employing over 4,000 people.

As a group, Chiesi is committed to the development and commercialization of innovative pharmaceutical solutions to improve the quality of human life. The company’s primary therapeutic areas of focus include neonatology, respiratory diseases and special care/rare diseases. Chiesi regularly goes “beyond the pill”, leveraging resources to support research, education and charitable partnerships aimed at improving care around the world.

The mission of Chiesi is to be recognized as a research-focused international group, developing and bringing innovative, value-added medical solutions to healthcare providers and their patients. The company is committed to achieving results while maintaining the highest level of ethics and integrity.

Chiesi USA offers qualified professionals the opportunity to build a purposeful career, focused on helping others, growing professionally, achieving a fulfilling work-life balance, meeting exciting challenges and engaging in important and rewarding work. The company is committed to helping each and every team member develop professionally and contribute to our extraordinary goal of changing patients’ lives. At Chiesi USA teamwork is paramount; with company success dependent on the growth and achievement of every single member.

To learn more about Chiesi, and to view current openings, please visit

Click here to celebrate Chiesi’s 80th anniversary -

Key Statistics

Ownership: Private

Web Site: Chiesi, USA


Company News
Cornerstone Therapeutics Inc. Announces Name Change To Chiesi USA, Inc. 4/28/2014 9:48:53 AM
Cornerstone Therapeutics Inc. Stockholders Approve Merger 2/4/2014 10:02:19 AM
Chiesi Farmaceutici SpA Completes Acquisition Of Cornerstone Therapeutics Inc. 2/4/2014 9:58:06 AM
Cornerstone Therapeutics Inc. Adjourns Special Meeting of Stockholders 2/3/2014 10:21:32 AM
Cornerstone Therapeutics Inc. Launches BETHKIS(R) (Tobramycin Inhalation Solution) For Management Of Cystic Fibrosis Patients With Pseudomonas Aeruginosa 11/21/2013 11:08:52 AM
Cornerstone Therapeutics Inc. Reports Third Quarter 2013 Financial Results 11/8/2013 9:11:04 AM
Cornerstone Therapeutics Inc. Announces Initiation of Phase 2 Clinical Trial of CPI-613 for the Treatment of Small Cell Lung Cancer 10/24/2013 9:40:12 AM
Chiesi Farmaceutici SpA to Buy Rest of Cornerstone Therapeutics Inc. for $255 Million 9/16/2013 6:52:01 AM
Cornerstone Therapeutics Inc. Initiates PERTZYE® (pancrelipase) Sales and Marketing Efforts for the Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis 7/30/2013 8:45:59 AM
Cornerstone Therapeutics Inc. Sues to Enforce Its CARDENE(R) I.V. Patents 7/25/2013 10:04:50 AM